Arkolith/Insider Trading/RXRX/Form 4

Khan Najat

CEO and President, DirectorRECURSION PHARMACEUTICALS, INC. (RXRX) · full profile →Form 4 · filed May 19, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2026Tax withholding(F)63K$3.04$191K2.2M

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002020969-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML